Financial Filings

1 – February – 12 Form 8-K

13 – January – 12 Form 8-K

9 – January – 12 Form 8-K

27 – December – 11 Form 8-K

21 – December – 11 Form 8-K

8 – December – 11 Form 8-Q

7 – December – 11 Form 8-Q

1 – November – 11 Form 10-Q

28 – October – 11 Form 8-K

13 – October – 11 Form S-3 – Registration statement under Securities Act of 1933

6 – October – 11 Form 8-K

5 – October – 11 Form 8-K/A

30 – September – 11 Form S-3 – Registration statement under Securities Act of 1933

13 – September – 11 Form 8-K

22 – August – 11 Form 8-K

12 – August – 11 Form 10-Q – Quarterly report [Sections 13 or 15(d)]

7 – July – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

1 – July – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

21 – June – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

8 – June – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits

8 – June – 11 Form 424B3 for AMPIO PHARMACEUTICALS, INC

25 – May – 11 Quarterly Income Statement for AMPIO PHARMACEUTICALS, INC.

20 – May – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.

13 – May – 11 Form 10-Q for AMPIO PHARMACEUTICALS, INC.

19 – April – 11 Form S-1 for Ampio Pharmaceuticals

19 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities

12 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities

4 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities

25 – March – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Regulation FD D

25 – March – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition

16 – March – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.

18 – February – 11 Form S-4/A for Ampio Pharmaceuticals

19 – February – 11 AMPIO PHARMACEUTICALS, INC. Financials

18 – February – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure

15 – February – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.

07 – January – 11 Form S-4 for AMPIO PHARMACEUTICALS, INC.

07 – January – 11 Form 8-K/A for AMPIO PHARMACEUTICALS, INC.

19 – November – 10 AMPIO PHARMACEUTICALS, INC. Financials

15 – November – 10 Form 10-Q for AMPIO PHARMACEUTICALS, INC.

12 – November – 10 Form 8-K for AMPIO PHARMACEUTICALS, INC.

11 – November – 10 Form S-1 for AMPIO PHARMACEUTICALS, INC.

17 – August – 10 Form 8-K/A for AMPIO PHARMACEUTICALS, INC.

16 – August – 10 Form 8-K for AMPIO PHARMACEUTICALS, INC.

26 – May – 10 AMPIO PHARMACEUTICALS, INC. Financials

17 – May – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report

14 – May – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements…

10 – May – 10 Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer

27 – Apr – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi

22 – Apr – 10 Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.

14 – Apr – 10 Ampio Pharmaceuticals, Inc. Appoints New Independent Director

12 – Apr – 10 Ampio Pharmaceuticals Contracts with St. Michael’s Hospital to Conduct Phase II Clinical Trial of Optina(TM) to Treat Diabetic Retinopathy

30 – Mar – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Ar

30 – Mar – 10 Ampio Pharmaceuticals, Inc. Reincorporates as a Delaware Corporation, Effects Name Change, and Announces Change in Trading Symbol to ‘AMPE’

Learn More About:

Premature Ejaculation (PE)

Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.

Diabetic Retinopathy

A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness

Diabetic Nephropathy

A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis

AMPE Stock Quote - delayed
	Last	Change
AMPE

Ampio News

01/31/2012 | Press Release

Ampio Pharmaceuticals, Inc. Announces Statistically Significant Improvement in Pain Relief for its Lead Product, Ampion™ in the Osteoarthritis of the Knee Trial

01/26/2012 | News

Register Now For AMPIO’s January 26, 2012 Outlook Call

01/17/2012 | Press Release

Ampio Pharmaceuticals' Zertane™ Patent Estate Bolstered by Two New European Patents

» See all Ampio news